Annigje van Es-Johansson Net Worth

Annigje van Es-Johansson biography

Dr. Annigje van Es-Johansson M.D. serves as Independent Director of the Company. Dr. An van Es-Johansson has served on our Board of Directors since December 2019. Since September 2018, she has served as the Chief Medical Officer for AlzeCure Pharma, a Swedish pharmaceutical company with a primary focus on Alzheimer’s disease. From May 2005 to September 2018, Dr. van Es-Johansson served in a range of executive roles of increasing responsibility at Sobi, an international rare disease company headquartered in Stockholm, Sweden, including as Vice President and Head of EMENAR Medical Affairs for Specialty Care and Partner Products from March 2013 to January 2018. Prior to her time at Sobi, Dr. van Es-Johansson served in leadership positions within large pharmaceutical and smaller biotechnology companies, including Roche, Eli Lilly, Active Biotech, and BioStratum. From 2004 to 2016 she was a member of the Scientific Adboard for Uppsala Bio and currently serves on the board of directors at BioInvent International AB (NASDAQ OMX Stockholm), Medivir AB (NASDAQ Stockholm), Plus Therapeutics, Inc. (NASDAQ: PSTV), and privately held Agendia BV. Dr. van Es-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. van Es-Johansson’s medical knowledge and experience in the pharmaceutical industry qualifies her to serve on the Board of Directors.

How old is Annigje Johansson?

Annigje Johansson is 60, he's been the Independent Director of Savara Inc since 2019. There are 5 older and 6 younger executives at Savara Inc. The oldest executive at Savara Inc is Richard Hawkins, 71, who is the Independent Director.

What's Annigje Johansson's mailing address?

Es's mailing address filed with the SEC is C/O PLUS THERAPEUTICS INC., 4200 MARATHON BOULEVARD, SUITE 200, AUSTIN, TX, 78756.

Insiders trading at Savara Inc

Over the last 8 years, insiders at Savara Inc have traded over $2,203,958 worth of Savara Inc stock and bought 6,103,761 units worth $15,290,245 . The most active insiders traders include Forest Baskett, Scott D Sandell et Anthony A. Jr. Florence. On average, Savara Inc executives and independent directors trade stock every 29 days with the average trade being worth of $348,922. The most recent stock trade was executed by Matthew Pauls on 28 December 2023, trading 84,000 units of SVRA stock currently worth $395,640.

What does Savara Inc do?

savara pharmaceuticals is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. the company’s lead product, aerovanc is the first dry powder inhaled antibiotic for the treatment of methicillin-resistant staphylococcus aureus (mrsa) infection in patients with cystic fibrosis (cf). for more information, please see savara’s website at www.savarapharma.com or www.aerovanc.com

Savara Inc executives and stock owners

Savara Inc executives and other stock owners filed with the SEC include:

• Dr. Badrul A. Chowdhury M.D., Ph.D.,
  Chief Medical Officer
• David Lowrance,
  Chief Financial Officer, Secretary
• David L. Lowrance,
  CFO & Sec.
• Ricky Sun,
  Independent Director
• Annigje van Es-Johansson,
  Independent Director
• Badrul Chowdhury,
  Chief Medical Officer
• Anne Erickson,
  IR Contact Officer
• David Ramsay,
  Independent Director
• Matthew Pauls,
  Chairman of the Board, Interim Chief Executive Officer
• Joseph McCracken,
  Independent Director
• Richard Hawkins,
  Independent Director
• Nevan Elam,
  Independent Director
• Dr. Peter Clarke Ph.D.,
  Exec. VP of Global Technical Operations
• Charles LaPree,
  Sr. VP of Global Regulatory Affairs & Quality Assurance
• Brian Maurer,
  Head of Clinical Operations
• Dr. Dhaval Desai M.D.,
  Head of Clinical Devel.
• Kate McCabe,
  Sr. VP of Legal Affairs
• Robert N Neville,
  Chief Executive Officer
• Yuri Pikover,
  Director
• Jaakko Taneli Jouhikainen,
  See Remarks
• Es Johansson An Van,
  Director
• Forest Baskett,
  10% owner
• Equity Opportunities 17, Ll...,
  
• Rick Yang,
  10% owner
• Paul Edward Walker,
  10% owner
• Scott D Sandell,
  10% owner
• Edward T Mathers,
  10% owner
• Mohamad Makhzoumi,
  10% owner
• Carmen Chang,
  10% owner
• Anthony A. Jr. Florence,
  10% owner
• Ali Behbahani,
  10% owner
• Raymond Dennis Pratt,
  Chief Medical Officer
• Robert Matthew Lutz,
  Chief Operating Officer